Hikma Pharmaceuticals
$35.89
429
+$0.53+1.51% Today
Statistics
Day High
35.35
Day Low
35.35
52W High
56.94
52W Low
31.8
Volume
200
Avg. Volume
1,203
Mkt Cap
0
P/E Ratio
9.69
Dividend Yield
4.77%
Dividend
1.71
Upcoming
Dividends
4.77%Dividend Yield
Sep 25
$0.72
May 25
$0.96
Sep 24
$0.64
May 24
$0.94
Sep 23
$0.5
10Y Growth
10.13%
5Y Growth
10.07%
3Y Growth
10.65%
1Y Growth
N/A
Earnings
26FebExpected
Expected EPS
79.7513223
Actual EPS
N/A
Financials
11.48%Profit Margin
Profitable3.13BRevenue
359MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow HKMPY. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap35.03B
Novartis
NVS
Mkt Cap297.32B
Pfizer
PFE
Mkt Cap161.09B
Abbvie
ABBV
Mkt Cap369.39B
Johnson & Johnson
JNJ
Mkt Cap585.7B
Merck
MRK
Mkt Cap298.84B
GSK
GSK
Mkt Cap113.29B
Sanofi
SNY
Mkt Cap116.63B
Astrazeneca
AZN
Mkt Cap315.47B
About
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.
Show more...
CEO
H.E Said Samih Taleb Darwazah
Employees
9500
Country
US
ISIN
US4312881091
Listings
0 Comments
Share your thoughts
FAQ
What is Hikma Pharmaceuticals stock price today?▼
The current price of HKMPY is $35.89 USD — it has increased by +1.51% in the past 24 hours. Watch Hikma Pharmaceuticals stock price performance more closely on the chart.
What is Hikma Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Hikma Pharmaceuticals stocks are traded under the ticker HKMPY.
Is Hikma Pharmaceuticals stock price growing?▼
HKMPY stock has risen by +2.35% compared to the previous week, the month change is a +11.93% rise, over the last year Hikma Pharmaceuticals has showed a -23.24% decrease.
When is the next Hikma Pharmaceuticals earnings date?▼
Hikma Pharmaceuticals is going to release the next earnings report on August 06, 2026.
What is Hikma Pharmaceuticals revenue for the last year?▼
Hikma Pharmaceuticals revenue for the last year amounts to 3.13B USD.
What is Hikma Pharmaceuticals net income for the last year?▼
HKMPY net income for the last year is 359M USD.
Does Hikma Pharmaceuticals pay dividends?▼
Yes, HKMPY dividends are paid semi-annual. The last dividend per share was 0.72 USD. As of today, Dividend Yield (FWD)% is 4.77%.
How many employees does Hikma Pharmaceuticals have?▼
As of April 09, 2026, the company has 9,500 employees.
In which sector is Hikma Pharmaceuticals located?▼
Hikma Pharmaceuticals operates in the Health Care sector.
When did Hikma Pharmaceuticals complete a stock split?▼
Hikma Pharmaceuticals has not had any recent stock splits.
Where is Hikma Pharmaceuticals headquartered?▼
Hikma Pharmaceuticals is headquartered in London, US.